SCHOLL HENDRIK PETER (Chief Medical Officer) sold 40.0% of their position (10K shares) of BELITE BIO, INC on the open market
Open‑market sale worth $1.45M — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 5 sales
Filed: 6/22/2026ACC: 0001193125-26-276615
Officer· Chief Medical Officer
Since Mar 2026
-10K
Net shares
Net seller
$1.45M
Total sold
5
Open market trades
0B · 5S
5
Total transactions
10K disposed
Non-Derivative Transactions5
American depositary share
Indirect
Shares
−96.00
Price / share
$143.90
Trade value
$13.81K
% of position
0.4%
6/18/2026
25K→24.90K
American depositary share
Indirect
Shares
−3.75K
Price / share
$144.66
Trade value
$542.19K
% of position
15.0%
6/18/2026
24.90K→21.16K
American depositary share
Indirect
Shares
−4.86K
Price / share
$145.43
Trade value
$706.96K
% of position
23.0%
6/18/2026
21.16K→16.30K
American depositary share
Indirect
Shares
−1.20K
Price / share
$146.24
Trade value
$175.35K
% of position
7.4%
6/18/2026
16.30K→15.10K
American depositary share
Indirect
Shares
−96.00
Price / share
$147.11
Trade value
$14.12K
% of position
0.6%
6/18/2026
15.10K→15K
Total
Net shares
−10K
Net value
-$1.45M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| American depositary share Indirect | 6/18/2026 | S · Sale | −96.00 | $143.90 | $13.81K | 0.4% | 25K | 24.90K |
| American depositary share Indirect | 6/18/2026 | S · Sale | −3.75K | $144.66 | $542.19K | 15.0% | 24.90K | 21.16K |
| American depositary share Indirect | 6/18/2026 | S · Sale | −4.86K | $145.43 | $706.96K | 23.0% | 21.16K | 16.30K |
| American depositary share Indirect | 6/18/2026 | S · Sale | −1.20K | $146.24 | $175.35K | 7.4% | 16.30K | 15.10K |
| American depositary share Indirect | 6/18/2026 | S · Sale | −96.00 | $147.11 | $14.12K | 0.6% | 15.10K | 15K |
| Total | −10K | -$1.45M | ||||||
Derivative Transactions0
No derivative transactions reported